• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Blood Purif . Characteristics and prognostic factors of SARS-CoV-2 Omicron variant infection in hemodialysis patients: a single-center study in Chin

tetano

Editor, Senior Moderator
Blood Purif


. 2023 Nov 16.
doi: 10.1159/000535244. Online ahead of print.
Characteristics and prognostic factors of SARS-CoV-2 Omicron variant infection in hemodialysis patients: a single-center study in China

Fan Zhang, Guoli Li, Jie Yu, Yiyu Shen, Yiya Yang, Shuangshuang Fu, Kanghan Liu, Yumei Liang, Xun Luo, Yinyin Chen
Abstract

Introduction: This study aimed to evaluate the characteristics and prognostic factors for coronavirus disease 2019 (COVID-19) patients on maintenance hemodialysis (HD).
Methods: All admitted HD patients who were infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) from December 1, 2022 to January 31, 2023 were included. Patients with pneumonia were further classified into the mild, moderate, severe and critical illness. Clinical symptoms, laboratory results, radiologic findings, treatment and clinical outcomes were collected. Independent risk factors for progression to critical disease, and in-hospital mortality were determined by the multivariate regression analysis. The receiver operating characteristic (ROC) analysis with the area under the curve (AUC) was used to evaluate the predictive performance of developing critical status and in-hospital mortality.
Results: A total of 182 COVID-19 patients with HD were included, with an average age of the 61.55 years. Out of the total, 84 (46.1%) patients did not have pneumonia and 98 (53.8%) patients had pneumonia. Among patients with pneumonia, 48 (49.0%) had moderate illness, 26 (26.5%) severe illness, and 24 (24.5%) critical illness, respectively. Elder age [HR (95% CI): 1.07 (1.01-1.13), P<0.01], increased levels of lactate dehydrogenase (LDH) [1.01 (1.003-1.01), P<0.01] and C-reactive protein (CRP) [1.01 (1.00-1.01), P=0.04] were risk factors for developing critical illness. Elder age [1.11 (1.03-1.19), P=0.01], increased procalcitonin (PCT) [1.07 (1.02-1.12), P=0.01], and LDH level [1.004 (1-1.01), P=0.03] were factors associated with increased risk of in-hospital mortality.
Conclusions: Age, CRP, PCT and LDH can be used to predict negative clinical outcomes for HD patients with COVID-19 pneumonia.


 
Back
Top Bottom